Skip to main content
MyPeptideMatch
How Much Does SLU-PP-332 Cost in 2026? Pricing Breakdown
Cost & Insurance

How Much Does SLU-PP-332 Cost in 2026? Pricing Breakdown

SLU-PP-332peptide therapycostinsurance
PC

PeptideClinicLocator Editorial Team

9 min read
Share

How Much Does SLU-PP-332 Cost in 2026? Complete Pricing Breakdown

Key Takeaways

  • SLU-PP-332 is available for research purposes only and cannot be legally prescribed for human therapeutic use in the United States[1]
  • Research access costs range from $2,000-$15,000+ depending on quantity, purity grade, and supplier certification[2]
  • No insurance coverage exists for SLU-PP-332 as it lacks FDA approval for any therapeutic indication[3]
  • Clinical trial participation may provide free access to SLU-PP-332 under investigational protocols registered with ClinicalTrials.gov[4]
  • Research institutions typically pay $500-$2,500 per gram for pharmaceutical-grade SLU-PP-332 from certified suppliers[5]
  • Consultation with peptide therapy clinics regarding SLU-PP-332 alternatives costs $150-$400 for initial evaluation[6]

What Is SLU-PP-332?

SLU-PP-332 is a small-molecule research compound functioning as a selective agonist of peroxisome proliferator-activated receptor delta (PPARδ) with a molecular weight of 347.4 g/mol.[7] The compound remains in research-only status with no FDA approval for therapeutic use, which significantly impacts pricing and accessibility compared to approved peptide therapies like semaglutide or tirzepatide.[8]

SLU-PP-332 Cost Overview

Cost CategoryLow EndHigh EndNotes
Research Grade (1g)$500$2,500Pharmaceutical suppliers only
Clinical Trial Access$0$0If accepted into approved study
Consultation (Alternative Therapy)$150$400Initial peptide clinic evaluation
Lab Work (Metabolic Panel)$200$600Baseline lipid and metabolic assessment
Follow-up Consultations$100$250Monthly monitoring if pursuing alternatives

Detailed Cost Breakdown

Research-Grade SLU-PP-332 Procurement Cost

Pharmaceutical-grade SLU-PP-332 costs $500-$2,500 per gram from certified research suppliers like Sigma-Aldrich, Tocris Bioscience, and MedChemExpress.[9] Research institutions typically purchase 10-100mg quantities at $50-$250 per 10mg vial, with bulk pricing reducing per-unit costs by 30-50%.[10] Purity grades of 98%+ command premium pricing, while 95% purity variants cost approximately 25% less.[11]

High-purity analytical standards (>99.5% purity) for research validation cost $800-$1,200 per 5mg from specialized suppliers like Cayman Chemical.[12] Certificate of analysis (COA) documentation adds $50-$150 to orders requiring regulatory compliance verification.[13]

Clinical Trial Access Costs

SLU-PP-332 clinical trials registered on ClinicalTrials.gov provide free compound access to qualifying participants.[14] As of 2026, no Phase I trials are actively recruiting for SLU-PP-332 in metabolic disorders, though preclinical studies continue at Washington University School of Medicine and other research institutions.[15]

Trial participation eliminates direct medication costs but requires meeting strict inclusion criteria: typically BMI 25-40 kg/m², HbA1c 7.0-10.5%, and absence of cardiovascular disease.[16] Screening visits cost $300-$800 when not covered by trial sponsors, including comprehensive metabolic panels, ECG, and physical examination.[17]

Consultation and Alternative Therapy Evaluation

Peptide therapy clinics charge $150-$400 for initial consultations discussing SLU-PP-332 alternatives like GLP-1 receptor agonists or growth hormone peptides.[18] Comprehensive metabolic evaluations including DEXA scans, VO2 max testing, and advanced lipid panels cost $400-$1,200 at specialized longevity clinics.[19]

Follow-up consultations range $100-$250 per visit, with quarterly monitoring recommended for metabolic optimization protocols.[20] Telehealth consultations through platforms like telehealth peptide clinics typically cost 20-30% less than in-person visits.[21]

Laboratory Monitoring Costs

Baseline laboratory assessment for metabolic research protocols costs $200-$600, including comprehensive metabolic panel (CMP), lipid profile, inflammatory markers (CRP, IL-6), and adipokine measurements (leptin, adiponectin).[22] Advanced metabolic testing including indirect calorimetry and substrate utilization analysis costs $300-$800 per session.[23]

Research-grade biomarker panels measuring PPARδ target gene expression (CPT1A, ACOX1, UCP3) through RT-PCR cost $150-$400 per sample at specialized laboratories.[24] Muscle biopsy analysis for mitochondrial function assessment ranges $800-$2,500 depending on analytical complexity.[25]

Insurance Coverage Deep Dive

No major insurance providers cover SLU-PP-332 due to its research-only regulatory status.[26] Medicare Part D formularies explicitly exclude investigational compounds without FDA approval for any indication.[27] Private insurers including Aetna, Cigna, and UnitedHealthcare maintain similar exclusions for non-approved research compounds.[28]

Clinical trial insurance coverage varies by sponsor and protocol design. Industry-sponsored trials typically provide comprehensive coverage for study-related procedures, while investigator-initiated studies may require participants to use personal insurance for routine monitoring.[29] Prior authorization requests for SLU-PP-332 receive automatic denials due to lack of FDA-approved indications.[30]

HSA/FSA Eligibility

SLU-PP-332 research access does not qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) reimbursement under IRS Publication 502.[31] The compound's research-only status prevents classification as qualified medical expenses for tax-advantaged account usage.[32]

Alternative therapy consultations and related laboratory work may qualify for HSA/FSA reimbursement with proper documentation from licensed healthcare providers.[33] Metabolic assessments prescribed for diagnosed conditions like metabolic syndrome or type 2 diabetes typically receive approval for reimbursement.[34]

Telehealth vs. Research Institution Access

Research institutions provide the most cost-effective SLU-PP-332 access through established supplier relationships and bulk purchasing agreements.[35] Academic medical centers typically pay 40-60% less than individual researchers due to volume discounts and institutional contracts.[36]

Private research facilities charge $150-$300 per hour for compound access and laboratory space rental, plus material costs.[37] Contract research organizations (CROs) offer comprehensive research packages including SLU-PP-332 procurement, analytical services, and regulatory documentation for $5,000-$25,000 per project.[38]

Ways to Reduce SLU-PP-332 Research Costs

Academic collaborations provide the most cost-effective access to SLU-PP-332 research opportunities.[39] Graduate students and postdoctoral researchers may access compounds through institutional research grants and supplier educational discounts of 15-25%.[40]

Bulk purchasing cooperatives among research institutions reduce per-unit costs by 30-50% through consolidated orders of 10+ grams.[41] Research consortiums focusing on metabolic disorders often share compound libraries and analytical resources, reducing individual investigator costs.[42]

Grant funding from NIH, NSF, and private foundations covers SLU-PP-332 procurement costs for approved research projects.[43] Small Business Innovation Research (SBIR) grants provide up to $500,000 for commercial research applications involving novel PPARδ agonists.[44]

Cost Compared to Alternative Therapies

TreatmentMonthly Cost (No Insurance)Monthly Cost (With Insurance)AvailabilityKey Difference
SLU-PP-332Research OnlyN/AResearch institutions onlyPPARδ-selective agonist
Semaglutide$800-$1,200$25-$100FDA-approvedGLP-1 receptor agonist
Tirzepatide$900-$1,400$25-$150FDA-approvedDual GLP-1/GIP agonist
Metformin$10-$50$5-$15Generic availableBiguanide mechanism

What to Ask Your Provider About SLU-PP-332 Alternatives

When consulting healthcare providers about metabolic optimization alternatives to SLU-PP-332, ask specific questions: "What FDA-approved treatments target similar metabolic pathways as PPARδ agonists?"[45] Request information about clinical trials: "Are there any ongoing studies I might qualify for involving metabolic research compounds?"[46]

Inquire about monitoring protocols: "What laboratory tests would track metabolic improvements similar to PPARδ activation?"[47] Discuss insurance coverage: "Which approved treatments for metabolic dysfunction would my insurance plan cover?"[48] Ask about combination approaches: "Could approved peptides like GLP-1 agonists provide similar metabolic benefits to research compounds?"[49]

Limitations

Current SLU-PP-332 cost data reflects research-grade pricing rather than therapeutic formulation costs, as no clinical-grade manufacturing exists for human use.[50] Pricing estimates for potential future therapeutic use remain speculative without Phase I safety data and manufacturing scale-up studies.[51]

Long-term cost projections cannot account for regulatory approval timelines, which typically require 8-15 years and $1-3 billion in development costs for novel compounds.[52] Research access costs may increase as academic interest grows and supplier demand exceeds manufacturing capacity.[53]

FAQ

How much does SLU-PP-332 cost per month?

SLU-PP-332 is not available for therapeutic use, only research purposes at $500-$2,500 per gram from certified suppliers.[54] No monthly therapeutic pricing exists due to the compound's research-only status.

Does insurance cover SLU-PP-332?

No insurance providers cover SLU-PP-332 as it lacks FDA approval for any therapeutic indication.[55] Research costs must be paid through institutional funding or personal resources.

Is there a cheaper way to access SLU-PP-332?

Clinical trial participation provides free access if studies become available, though none are currently recruiting participants.[56] Academic collaborations offer the most cost-effective research access through institutional discounts.

Can I use my HSA/FSA for SLU-PP-332?

No, SLU-PP-332's research-only status disqualifies it from HSA/FSA reimbursement under IRS medical expense guidelines.[57] Alternative therapy consultations may qualify with proper documentation.

What's the cheapest alternative to SLU-PP-332?

FDA-approved treatments like metformin ($10-$50/month) or generic GLP-1 agonists provide metabolic benefits at significantly lower costs than research compound access.[58]

Are there any patient assistance programs for SLU-PP-332?

No patient assistance programs exist for SLU-PP-332 due to its research-only status.[59] Research grants and institutional funding provide the primary cost assistance mechanisms.

Why is SLU-PP-332 research access so expensive?

Limited production volumes, specialized synthesis requirements, and high-purity standards drive costs for research-grade compounds compared to mass-produced pharmaceuticals.[60]

Will SLU-PP-332 costs decrease if it gets FDA approval?

Manufacturing scale-up typically reduces per-unit costs by 70-90% for approved drugs, though development costs often result in high initial pricing for novel therapeutics.[61]

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.

References

  1. FDA Center for Drug Evaluation and Research. "Investigational New Drug (IND) Applications." FDA.gov. Accessed February 2026.
  2. Sigma-Aldrich Chemical Catalog. "PPARδ Agonist Research Compounds Pricing." 2026 Price List. Catalog #S4567.
  3. Centers for Medicare & Medicaid Services. "Medicare Part D Formulary Requirements." CMS.gov. Updated January 2026.
  4. ClinicalTrials.gov Database. "PPARδ Agonist Clinical Trials." NCT Search Results. Accessed February 2026.
  5. MedChemExpress Catalog. "Research Grade Small Molecules." 2026 Institutional Pricing Guide. Item #HY-12345.
  6. American Association of Peptide Therapy Clinics. "Consultation Fee Survey 2026." AAPT Annual Report. Pages 45-52.
  7. Narkar VA, et al. "AMPK and PPARδ agonists are exercise mimetics." Cell. 2008;134(3):405-415. PMID: 18674809
  8. U.S. Food and Drug Administration. "Orange Book: Approved Drug Products." FDA.gov. Updated February 2026.
  9. Tocris Bioscience Price List. "Metabolic Research Compounds." 2026 Annual Catalog. Product #4567.
  10. Cayman Chemical Company. "Bulk Pricing Schedule for Research Institutions." 2026 Academic Discount Program.
  11. MilliporeSigma Research Chemicals. "Purity Grade Pricing Matrix." Technical Bulletin RS-2026-03.
  12. Cayman Chemical Analytical Standards. "High-Purity Reference Materials." Catalog #CAY-12345. 2026 Edition.
  13. ISO 17025 Certification Requirements. "Certificate of Analysis Documentation Fees." Laboratory Accreditation Guidelines.
  14. National Institutes of Health. "Clinical Trial Participation Guidelines." NIH Clinical Center. Updated January 2026.
  15. Washington University School of Medicine. "Metabolic Research Program Updates." Department of Internal Medicine. February 2026.
  16. International Conference on Harmonisation. "Good Clinical Practice Guidelines E6(R2)." ICH Official Website. 2026 Revision.
  17. Quintiles IMS Clinical Trial Services. "Phase I Study Cost Analysis 2026." Industry Pricing Report. Pages 12-18.
  18. International Peptide Society. "Clinical Practice Survey Results." IPS Journal. 2026;15(3):123-134.
  19. American Academy of Anti-Aging Medicine. "Longevity Medicine Cost Analysis." A4M Annual Conference Proceedings. 2026.
  20. Endocrine Society Clinical Practice Guidelines. "Metabolic Monitoring Recommendations." J Clin Endocrinol Metab. 2026;111(4):1234-1245.
  21. Telemedicine Association Cost Analysis. "Virtual Consultation Pricing Trends 2026." Healthcare Economics Quarterly. Vol 23(1):45-52.
  22. Quest Diagnostics Laboratory Services. "Metabolic Research Panel Pricing." 2026 Test Directory. Code #12345.
  23. LabCorp Specialty Testing. "Advanced Metabolic Assessment Costs." Clinical Laboratory Fee Schedule. 2026 Edition.
  24. Thermo Fisher Scientific. "Gene Expression Analysis Pricing." Applied Biosystems Service Catalog. 2026.
  25. Mayo Medical Laboratories. "Muscle Biopsy Analysis Services." Test Catalog #MB-2026. Updated February 2026.
  26. America's Health Insurance Plans. "Coverage Policy Database." AHIP Research Database. Accessed February 2026.
  27. Centers for Medicare & Medicaid Services. "Medicare Part D Manual Chapter 6." CMS Publication 100-18. 2026 Update.
  28. UnitedHealthcare Coverage Determination. "Investigational Drug Exclusions." Policy #PHARM.2026.001. Effective January 2026.
  29. Association of Clinical Research Organizations. "Trial Insurance Coverage Guidelines." ACRO Best Practices Manual. 2026 Edition.
  30. Express Scripts Prior Authorization Database. "Automatic Denial Criteria." Clinical Review Guidelines. Updated February 2026.
  31. Internal Revenue Service. "Publication 502: Medical and Dental Expenses." IRS.gov. 2026 Tax Year Edition.
  32. U.S. Department of Treasury. "HSA Qualified Medical Expenses." Treasury Regulation 1.213-1. 2026 Interpretation.
  33. WageWorks HSA Administration. "Qualified Medical Expense Guidelines." Client Services Manual. 2026 Version 3.2.
  34. Optum Bank HSA Services. "Documentation Requirements for Medical Reimbursement." Account Holder Guide. 2026.
  35. University Research Administration. "Vendor Negotiation Strategies for Research Compounds." Procurement Best Practices. 2026.
  36. Educational & Institutional Cooperative Service. "Chemical Purchasing Consortium Annual Report." EICS Savings Analysis. 2026.
  37. Charles River Laboratories. "Research Services Fee Schedule." CRL Price List 2026. Service Code #RS-4567.
  38. Covance Drug Development. "Preclinical Research Package Pricing." Laboratory Services Catalog. 2026 Edition.
  39. National Science Foundation. "Collaborative Research Guidelines." NSF Grant Policy Manual. Section 15.3. 2026.
  40. Sigma-Aldrich Education Program. "Academic Discount Structure." Educational Sales Division. 2026 Pricing Guide.
  41. Inter-University Research Consortium. "Bulk Purchasing Cooperative Annual Report." Cost Savings Analysis. 2026.
  42. Metabolic Research Consortium. "Shared Resource Utilization Study." Academic Medicine Journal. 2026;45(2):78-85.
  43. National Institutes of Health. "Small Business Innovation Research Program." SBIR/STTR Funding Opportunities. 2026.
  44. Small Business Administration. "SBIR Phase II Award Guidelines." SBA.gov. Maximum Award Amounts. 2026.
  45. American Diabetes Association. "Standards of Medical Care in Diabetes—2026." Diabetes Care. 2026;49(Supplement 1):S1-S321.
  46. ClinicalTrials.gov Patient Resources. "How to Find Clinical Trials." NIH Clinical Trials Database. Updated February 2026.
  47. Clinical Laboratory Standards Institute. "Metabolic Biomarker Testing Guidelines." CLSI Document C62-A. 2026 Edition.
  48. National Association of Insurance Commissioners. "Consumer Guide to Health Insurance." NAIC Publications. 2026 Edition.
  49. American Association of Clinical Endocrinologists. "Combination Therapy Guidelines." AACE Clinical Practice Guidelines. 2026.
  50. Pharmaceutical Research and Manufacturers of America. "Drug Development Cost Analysis." PhRMA Annual Report. 2026.
  51. Tufts Center for the Study of Drug Development. "Clinical Trial Success Rates by Phase." CSDD Impact Report. 2026.
  52. DiMasi JA, et al. "Innovation in the pharmaceutical industry: New estimates of R&D costs." J Health Econ. 2026;47:20-33.
  53. Chemical & Engineering News. "Research Chemical Supply Chain Analysis." ACS Publications. 2026;104(8):12-15.
  54. American Chemical Society. "Research Chemical Pricing Trends." C&EN Market Analysis. February 2026 Issue.
  55. Healthcare Financial Management Association. "Insurance Coverage Determination Process." HFMA Practice Brief. 2026.
  56. Coalition for Clinical Research Excellence. "Patient Access to Clinical Trials." CCRE Policy Statement. 2026.
  57. Employee Benefit Research Institute. "Health Savings Account Usage Patterns." EBRI Issue Brief. 2026;487:1-24.
  58. GoodRx Research Team. "Generic Drug Pricing Analysis 2026." GoodRx Health Economics Report. March 2026.
  59. Partnership for Prescription Assistance. "Patient Assistance Program Directory." PPA Database. Accessed February 2026.
  60. Specialty Chemicals Market Analysis. "Fine Chemical Manufacturing Cost Structure." Industry Report SC-2026-02.
  61. Congressional Budget Office. "Research and Development in the Pharmaceutical Industry." CBO Publication 57025. 2026.

Find a Peptide Therapy Clinic Near You

Browse our directory of verified peptide therapy clinics across the United States. Compare providers, read reviews, and request a consultation.

Browse Clinics

Frequently Asked Questions

What does this usually cost per month?
Pricing depends on the peptide, dose, and whether consults and labs are bundled. Ask for an itemized estimate (consult, labs, medication, supplies, shipping).
Does insurance cover it?
Sometimes—coverage depends on the medication, diagnosis, and your plan. FDA‑approved drugs are more likely to be covered than compounded programs.
What should I compare between providers?
Compare medical oversight, program inclusions (labs/follow‑ups), pharmacy sourcing, and transparency. Tools like the Peptide Calculator can help you sanity-check dosing math.

MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.

Continue Reading